This content is restricted.
Brief
The Commission Implementing Regulation (EU) 2024/2563 amends Implementing Regulation (EU) 2022/1646 regarding national risk-based control plans and surveillance plans. The regulation clarifies that Member States should submit their surveillance plan to the Commission, transmit data to EFSA, and includes justifications for selected substances and species in the control plans. This amendment aims to improve consistency and transparency in official controls, particularly with regard to pharmacologically active substances. Compliance considerations include submitting updated national risk-based control plans by 30 June each year and transmitting relevant data to EFSA by 31 August.
Highlights content goes here...
This content is restricted.
